Advance online publication

The latest articles are published online ahead of print (AOP) on a weekly basis. These online versions are definitive and may be cited using the digital object identifier (DOI).


Review

Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells

Liqing Wang, Edwin F. de Zoeten, Mark I. Greene & Wayne W. Hancock

Published online: 26 October 2009 | doi:10.1038/nrd3031

Many inhibitors of histone deacetylases (HDACs) are in trials in patients with cancer, but a subset of HDAC inhibitors also have anti-inflammatory or immunosuppressive effects that may be of therapeutic benefit in autoimmune diseases or post-transplantation. Hancock and colleagues describe these effects, highlighting the importance of the ability of some HDAC inhibitors to enhance the production and suppressive functions of FOXP3+ regulatory T cells, and discuss the potential to develop class- or subclass-specific HDAC inhibitors as novel immunotherapies.

Top

Perspectives

Opinion

The future of drug development: advancing clinical trial design

John Orloff, Frank Douglas, Jose Pinheiro, Susan Levinson, Michael Branson, Pravin Chaturvedi, Ene Ette, Paul Gallo, Gigi Hirsch, Cyrus Mehta, Nitin Patel, Sameer Sabir, Stacy Springs, Donald Stanski, Matthias R. Evers, Edd Fleming, Navjot Singh, Tony Tramontin & Howard Golub

Published online: 09 October 2009 | doi:10.1038/nrd3025

Orloff and colleagues describe how moving from the traditional approach to clinical trials based on sequential, distinct phases towards a more integrated strategy that increases flexibility and maximizes the use of accumulated knowledge could have a key role in improving the efficiency and cost-effectiveness of drug development. Using examples in which novel trial designs have been successfully applied, they also illustrate the use of the tools involved, such as Bayesian methodologies, and discuss the advantages and challenges for their more widespread implementation.


Top

About AOP

Until print versions of AOP papers are published, they should be cited in the style "Nature Reviews Drug Discovery AOP, published online day month year; doi:10.1038/nrdXXX". Once the print version (identical to the AOP) is published, it should be cited as follows: "Nature Reviews Drug Discovery volume number, page range (year); doi:10.1038/nrdXXX".

Extra navigation

Open Innovation Challenges

naturejobs

  • Data Manager

    • Philip Morris International (PMI)
    • Neuchatel Switzerland
  • PhD positions

    • Gregor Mendel Institute of Molecular Plant Biology (GMI)
    • Vienna, Austria, Dr. Bohr-Gasse, 1030

Advertisement